ALB and chronic kidney disease: Regarding the main binding sites on HSA, as CMPF displaces PAA on site I, binding to site II is tight enough that it is not replaced by either IS or PCS, even though the concentrations of the later toxins are significantly higher than PAA in CKD patients [28,37].